Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Prevalence of factor V G1691A, factor II G20210A, methylenetetrahydrofolate reductase C677T and endothelial protein C receptor 23 bp insertion polymorphisms in indigenous population of Nepal.

Patil A, Poudyal BS, Kapali SM, Ghosh K, Shetty S.

Ann Hematol. 2013 Jan;92(2):261-2. doi: 10.1007/s00277-012-1544-9. Epub 2012 Aug 11. No abstract available.

PMID:
22885990
2.
3.

An Arab selective gradient in the distribution of factor V G1691A (Leiden), prothrombin G20210A, and methylenetetrahydrofolate reductase (MTHFR) C677T.

Ameen G, Irani-Hakime N, Fawaz NA, Mahjoub T, Almawi WY.

J Thromb Haemost. 2005 Sep;3(9):2126-7. No abstract available.

4.

-455G/A beta-fibrinogen gene polymorphism, factor V Leiden, prothrombin G20210A mutation and MTHFR C677T, and placental vascular complications.

Camilleri RS, Peebles D, Portmann C, Everington T, Cohen H.

Blood Coagul Fibrinolysis. 2004 Mar;15(2):139-47.

PMID:
15091001
5.

Role of thrombotic risk factors in end-stage renal disease.

Tripathi G, Sankhwar SN, Sharma RK, Baburaj VP, Agrawal S.

Clin Appl Thromb Hemost. 2010 Apr;16(2):132-40. doi: 10.1177/1076029609335911. Epub 2009 Jun 10.

PMID:
19520684
6.

Factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T are not associated with coronary artery disease and type 2 diabetes mellitus in western Iran.

Rahimi Z, Nomani H, Mozafari H, Vaisi-Raygani A, Madani H, Malek-Khosravi S, Parsian A.

Blood Coagul Fibrinolysis. 2009 Jun;20(4):252-6. doi: 10.1097/MBC.0b013e3283255487.

PMID:
19349859
7.

Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review.

Morrison ER, Miedzybrodzka ZH, Campbell DM, Haites NE, Wilson BJ, Watson MS, Greaves M, Vickers MA.

Thromb Haemost. 2002 May;87(5):779-85. Review.

PMID:
12038776
8.

The plasminogen activator inhibitor (PAI)-1 promoter 4G/4G genotype is not associated with ischemic stroke in a population of German children. Childhood Stroke Study Group.

Nowak-Göttl U, Sträter R, Kosch A, von Eckardstein A, Schobess R, Luigs P, Nabel P, Vielhaber H, Kurnik K, Junker R.

Eur J Haematol. 2001 Jan;66(1):57-62.

PMID:
11168509
9.

Prevalence of factor V Leiden G1691A, MTHFR C677T, and prothrombin G20210A among Asian Indian sickle cell patients.

Pandey SK, Meena A, Kishor K, Mishra RM, Pandey S, Saxena R.

Clin Appl Thromb Hemost. 2012 Jun;18(3):320-3. doi: 10.1177/1076029611425830. Epub 2011 Nov 14.

PMID:
22084413
10.

Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.

Mueller T, Marschon R, Dieplinger B, Haidinger D, Gegenhuber A, Poelz W, Webersinke G, Haltmayer M.

J Vasc Surg. 2005 May;41(5):808-15.

11.

The prevalence of factor V G1691A but not of prothrombin G20210A and methylenetetrahydrofolate reductase C677T is remarkably low in French Basques.

Bauduer F, Zivelin A, Ducout L, Shpringer E, Seligsohn U.

J Thromb Haemost. 2004 Feb;2(2):361-2. No abstract available.

13.
14.

Frequency of three prothrombotic polymorphisms among Syrian population: factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase C677T.

Jarjour RA, Ammar S, Majdalawi R.

Ann Hum Biol. 2017 Feb;44(1):70-73. doi: 10.3109/03014460.2015.1119308. Epub 2015 Dec 10.

PMID:
26560857
15.
16.

Inherited prothrombotic risk factors in Turkish children with acute lymphoblastic leukemia: significance of concomitant genetic mutation.

Torun YA, Patiroglu T, Ozdemir MA, Ozkul Y, Ekici A, Karakukcu M.

Clin Appl Thromb Hemost. 2012 Mar-Apr;18(2):218-21. doi: 10.1177/1076029611412366. Epub 2011 Aug 25.

PMID:
21873357
17.

Hyperhomocysteinemia increases the risk of venous thrombosis independent of the C677T mutation of the methylenetetrahydrofolate reductase gene in selected Brazilian patients.

Morelli VM, Lourenço DM, D'Almeida V, Franco RF, Miranda F, Zago MA, Noguti MA, Cruz E, Kerbauy J.

Blood Coagul Fibrinolysis. 2002 Apr;13(3):271-5.

PMID:
11943942
18.
19.

Prevalence of thrombotic risk factors among beta-thalassemia patients from Western Iran.

Rahimi Z, Ghaderi M, Nagel RL, Muniz A.

J Thromb Thrombolysis. 2008 Dec;26(3):229-33. Epub 2007 Nov 4.

PMID:
17982733
20.

Factor V Leiden--the commonest molecular defect in arterial and venous thrombophilia in India.

Ahmed RP, Gupta PK, Kannan M, Choudhry VP, Saxena R.

Thromb Res. 2003 Apr 15;110(1):19-21. No abstract available.

PMID:
12877904

Supplemental Content

Support Center